Copyright
©The Author(s) 2020.
World J Clin Cases. Jun 26, 2020; 8(12): 2647-2654
Published online Jun 26, 2020. doi: 10.12998/wjcc.v8.i12.2647
Published online Jun 26, 2020. doi: 10.12998/wjcc.v8.i12.2647
Items | Factors | Values at admission | Postoperative values | Reference range |
Thyroid function | Parathyroid hormone | 7.96 pmol/L | 7.11 pmol/L | 1.6-6.9 |
Thyroid-stimulating hormone | 7.36 μIU/L | 2.24 μIU/L | 0.27-4.2 | |
Total T4 | 64.68 nmol/L | 79.12 nmol/L | 78.38-157.4 | |
Pituitary hormone | Prolactin | 17.13 ng/mL | 25.67 ng/mL | 1.61-18.77 |
Tumor biomarkers | Alpha-fetoprotein | 3.83 ng/mL | - | 0-25 |
Carbohydrate antigen 19-9 | 15.17 U/mL | - | < 37 | |
Carcinoembryonic antigen | 3.51 ng/mL | - | < 5 | |
Bone metabolism | Β-collagen-specific sequence | 1.21 ng/mL | - | 0.3-0.6 |
Total type I collagen amino-terminal extension peptide | 204.4 ng/mL | - | 20.25-76.31 | |
Diabetes | Fasting insulin | 55.29 μU/mL | 9.95 μU/mL | 2.6-24.9 |
Fasting blood glucose | 1.79 mmol/L | 3.98 mmol/L | 3.9-6.1 | |
Fasting C-peptide | 5.06 ng/mL | 1.81 ng/mL | 1.6-6.9 | |
Insulin release index | 1.31 | 0.2 | < 0.3 |
- Citation: Ma CH, Guo HB, Pan XY, Zhang WX. Comprehensive treatment of rare multiple endocrine neoplasia type 1: A case report. World J Clin Cases 2020; 8(12): 2647-2654
- URL: https://www.wjgnet.com/2307-8960/full/v8/i12/2647.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i12.2647